(Q35210164)

English

Glucagon-like peptide 1 receptor agonist therapy is more efficacious than insulin glargine for poorly controlled type 2 diabetes: A systematic review and meta-analysis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 August 2017

0 references

Glucagon-like peptide 1 receptor agonist therapy is more efficacious than insulin glargine for poorly controlled type 2 diabetes: A systematic review and meta-analysis (English)

1 reference

Europe PubMed Central

7 August 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

insulin glargine

1 reference

based on heuristic

inferred from title

author name string

Fu-peng Liu

1

1 reference

Europe PubMed Central

7 August 2017

Jian-jun Dong

2

1 reference

Europe PubMed Central

7 August 2017

Qing Yang

3

1 reference

Europe PubMed Central

7 August 2017

Xian-zhong Xue

4

1 reference

Europe PubMed Central

7 August 2017

Zhong-fa Ren

5

1 reference

Europe PubMed Central

7 August 2017

Yi-zhang Gan

6

1 reference

Europe PubMed Central

7 August 2017

Lin Liao

7

1 reference

Europe PubMed Central

7 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

10 September 2014

1 reference

Europe PubMed Central

7 August 2017

Journal of diabetes

1 reference

Europe PubMed Central

7 August 2017

7

1 reference

Europe PubMed Central

7 August 2017

3

1 reference

Europe PubMed Central

7 August 2017

322-328

1 reference

Europe PubMed Central

7 August 2017

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12200

21 January 2018

Standards of medical care in diabetes--2007.

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12200

21 January 2018

Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12200

21 January 2018

Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12200

21 January 2018

Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12200

21 January 2018

Therapeutics of diabetes mellitus: focus on insulin analogues and insulin pumps

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12200

21 January 2018

A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis.

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12200

21 January 2018

Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients.

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12200

21 January 2018

The role of basal insulin and glucagon-like peptide-1 agonists in the therapeutic management of type 2 diabetes--a comprehensive review

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12200

21 January 2018

The role of GLP-1 mimetics and basal insulin analogues in type 2 diabetes mellitus: guidance from studies of liraglutide

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12200

21 January 2018

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12200

21 January 2018

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12200

21 January 2018

Quantifying heterogeneity in a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12200

21 January 2018

One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12200

21 January 2018

Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12200

21 January 2018

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12200

21 January 2018

Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12200

21 January 2018

Efficacy and safety profile of exenatide once weekly compared with insulin once daily in Japanese patients with type 2 diabetes treated with oral antidiabetes drug(s): results from a 26-week, randomized, open-label, parallel-group, multicenter, noni

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12200

21 January 2018

Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12200

21 January 2018

Importance of Weight Management in Type 2 Diabetes: Review with Meta-analysis of Clinical Studies

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12200

21 January 2018

Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12200

21 January 2018

Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12200

21 January 2018

Identifiers

10.1111/1753-0407.12200

1 reference

Europe PubMed Central

7 August 2017

release_pphxxoppt5c7jk2nrzt45af72y

1 reference

https://api.fatcat.wiki/v0/release/pphxxoppt5c7jk2nrzt45af72y

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

7 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35210164&oldid=1861608984"